T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
2 hedge funds and large institutions have $0 invested in T2 Biosystems, Inc in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 25 closing their positions.
92% less funds holding
Funds holding: 26 → 2 (-24)
96% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 25
100% less capital invested
Capital invested by funds: $366K → $0 (-$366K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$65K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$59.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$58.5K |
| 4 |
Squarepoint
New York
|
-$39.1K |
| 5 |
BlackRock
New York
|
-$32.3K |
TTOO Hedge Fund Activity: Q1 2025 in Review
2 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2025, worth a combined $0 — down 100% from $366K a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of TTOO and 1 opened new positions — a net loss of 24 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $65K sold.
- 2 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2025, down from 26 in Q4 2024.
- Funds reported $0 of T2 Biosystems, Inc stock for Q1 2025, down 100% quarter-over-quarter.
- 1 fund opened new T2 Biosystems, Inc positions in Q1 2025 and 25 closed out, a net change of -24 holders.
- The largest T2 Biosystems, Inc seller in Q1 2025 was Vanguard Group, an estimated $65K sold.
Based on aggregated 13F filings for Q1 2025.